Table 3 Risk factors for metastatic infection of KPLA in diabetic patients

Male

63 (70.0)

8 (66.7)

0.814

0.76 (0.16–3.59)

0.733

Age in years

64.4 ± 14.2

63.2 ± 16.0

0.779

1.02 (0.97–1.08)

0.430

Underlying diseases

 Malignancy

10 (11.8)

1 (8.3)

0.772

–

–

 Alcoholism

4 (4.8)

1 (8.3)

0.564

–

–

 Chronic kidney disease

9 (10.6)

0 (0)

0.999

–

–

 Liver cirrhosis

2 (2.2)

0 (0)

0.999

–

–

 Congestive heart failure

2 (2.2)

0 (0)

0.999

–

–

 Chronic lung disease

1 (1.1)

0 (0)

1.000

–

–

Newly diagnosed diabetes

21 (23.3)

4 (33.3)

0.453

–

–

HbA_1c

9.1 ± 2.3

11.0 ± 2.3

0.015

1.50 (1.01–2.25)

0.047

Cryptogenic origin

80 (88.9)

12 (100)

0.999

–

–

Abscess locations in both lobes

18 (20.0)

5 (41.7)

0.102

1.48 (0.29–7.60)

0.646

Abscess size < 5 cm

36 (40)

9 (75)

0.032

4.72 (1.09–20.52)

0.038

Gas forming

11 (12.2)

1 (8.3)

0.693

–

–

Multiple abscesses

29 (32.2)

8 (66.7)

0.028

3.03 (0.62–14.74)

0.170

Initial laboratory value

 Leucocyte count, × 10³/μL

13.2 ± 5.5

13.9 ± 6.8

0.653

–

–

 Platelet, × 10³/μL

225 ± 117

209 ± 113

0.654

–

–

 C-reactive protein, mg/dL

19.5 ± 9.6

22.3 ± 9.6

0.339

–

–

 Glucose, mg/dL

284 ± 150

380 ± 229

0.071

1.00 (0.99–1.00)

0.728